Skip to main content

Table 2 Baseline characteristics

From: Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography

  Standard of care
(N = 31)
Alirocumab
(N = 30)
Age, yrs 61.3 ± 9.9 61.3 ± 8.9
Male 74.2 (23) 66.7 (20)
Diabetes 25.8 (8) 23.3 (7)
Current smoker 25.8 (8) 30 (9)
Hypertension 61.3 (19) 56.7 (17)
Prior MI 9.7 (3) 13.3 (4)
Prior stroke 3.2 (1) 10.0 (3)
ACS 41.9 (13) 36.7 (11)
Antiplatelet 100 (31) 100 (30)
Beta-blocker 90.3 (28) 93.3 (28)
ACEI/ARB 64.5 (20) 60.0 (18)
Chronic statin before enrollment 32.3 (10) 26.7 (8)
Imaged artery
 Left anterior desending 41.9 (13) 43.3 (13)
 Left circumflex 22.6 (7) 26.7 (8)
 Right coronary 32.2 (10) 30.0 (9)
 Others 3.2 (1) 0
  1. ACS acute coronary syndrome, MI myocardial infarction, ACEI/ARB angiotensin-converting enzyme inhibitors/angiotensin receptor blockers